Sarah Kiely
Investor Relations Contact at PROQR THERAPEUTICS N.V.
Profile
Sarah Kiely is currently the VP-Investor Relations & Corporate Affairs at ProQR Therapeutics NV.
Prior to her current position, she worked as the Director-Investor Relations & Communications at ImmunoGen, Inc. from 2012 to 2019.
Ms. Kiely holds an MBA from Boston University and an undergraduate degree from Boston College.
Sarah Kiely active positions
Companies | Position | Start |
---|---|---|
PROQR THERAPEUTICS N.V. | Investor Relations Contact | 30/09/2019 |
Former positions of Sarah Kiely
Companies | Position | End |
---|---|---|
IMMUNOGEN, INC. | Investor Relations Contact | 30/06/2019 |
Training of Sarah Kiely
Boston University | Masters Business Admin |
Boston College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
PROQR THERAPEUTICS N.V. | Health Technology |
Private companies | 1 |
---|---|
ImmunoGen, Inc.
ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Sarah Kiely